Palantir Revenue Surges 85%, Yet Stock Slips This Year
Palantir delivered an 85% year-over-year revenue surge in Q1 2026 and lifted full-year targets, but the shares are do...
When To Choose Stock Picking
Stock picking requires research and discipline; assess whether your time, resources, and goals justify active selection over passive options.
17,093 articles
Fennec (FENC) 2026 Earnings: Q1 Outlook and Takeaways
Investors eye the Fennec Q1 2026 call to gauge milestones, cash runway, and potential catalysts. This guide breaks do...
Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Broadcom's Revenue Just Soared: AI Demand and Stock
Broadcom is riding a powerful AI wave, with revenue in key AI-adjacent areas jumping. Yet the stock moved lower after...
Glorious Growth Stocks During the Latest Tech Sell-Off
When tech stocks wobble, patient investors can uncover glorious growth stocks during downturns. This piece highlights...
Stock Market Today, June: Marvell Surges on Target Hike
June brought a tech-led rally as Marvell Technology jumped on a price target upgrade. This piece breaks down the move...
Stock Market Today, June: AbbVie Cash Offer Boosts Apogee
A major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...
Market Punished Sweetgreen That Could Define Buy Opportunity
Sweetgreen faced a rough spell as the market punished sweetgreen that once looked unstoppable. Now, smart investors w...
Price Prediction: Costco Stock Could Double by 2032
Costco stock sits near a multi-quarter high as membership growth and stronger store sales bolster fundamentals. The b...
IBM: Should Investors Crash or Stay Put in 2026 and Beyond?
A 25 percent drop often triggers fear and temptation to buy the dip. This article breaks down IBM s recent results, t...
Unfortunate News Hides Behind a 1300% Rigetti Surge
Rigetti Computing stunned markets with a blistering rally, but behind the numbers lies a complicated story. This piec...
Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status